Skip to Main Content
Table 4 —

Prevalence and RR of CHD*, MI, and stroke in relation to the presence of the metabolic syndrome

Metabolic syndrome
RRP
YesNo
NGT (n = 1,808) 
 CHD 9.2 4.1 1.73 (1.01–2.95) 0.04 
 Previous MI 3.1 1.6 1.24 (0.52–2.97) 0.62 
 Previous stroke 2.2 1.6 1.31 (0.48–3.62) 0.59 
IFG/IGT (n = 685) 
 CHD 11.0 5.3 1.82 (0.98–3.38) 0.06 
 Previous MI 5.8 2.2 2.03 (0.81–5.08) 0.13 
 Previous stroke 3.6 0.9 3.64 (1.01–13.13) 0.05 
Type 2 DM (n = 1,430) 
 CHD 27.1 13.5 2.23 (1.52–3.26) <0.001 
 Previous MI 11.2 4.7 2.26 (1.25–4.10) 0.007 
 Previous stroke 5.7 2.9 1.79 (0.85–3.79) 0.13 
All subjects (n = 3,928) 
 CHD 21.4 5.5 2.96 (2.36–3.72) <0.001 
 Previous MI 9.0 2.1 2.63 (1.86–3.72) <0.001 
 Previous stroke 4.8 1.4 2.27 (1.47–3.50) <0.001 
Metabolic syndrome
RRP
YesNo
NGT (n = 1,808) 
 CHD 9.2 4.1 1.73 (1.01–2.95) 0.04 
 Previous MI 3.1 1.6 1.24 (0.52–2.97) 0.62 
 Previous stroke 2.2 1.6 1.31 (0.48–3.62) 0.59 
IFG/IGT (n = 685) 
 CHD 11.0 5.3 1.82 (0.98–3.38) 0.06 
 Previous MI 5.8 2.2 2.03 (0.81–5.08) 0.13 
 Previous stroke 3.6 0.9 3.64 (1.01–13.13) 0.05 
Type 2 DM (n = 1,430) 
 CHD 27.1 13.5 2.23 (1.52–3.26) <0.001 
 Previous MI 11.2 4.7 2.26 (1.25–4.10) 0.007 
 Previous stroke 5.7 2.9 1.79 (0.85–3.79) 0.13 
All subjects (n = 3,928) 
 CHD 21.4 5.5 2.96 (2.36–3.72) <0.001 
 Previous MI 9.0 2.1 2.63 (1.86–3.72) <0.001 
 Previous stroke 4.8 1.4 2.27 (1.47–3.50) <0.001 

Data are % and RR (95% CI).

*

Defined as typical chestpain/use of nitroglycerine/previous MI;

definition of the syndrome was based on the recent WHO proposal (17);

adjusted for age and sex.

Close Modal

or Create an Account

Close Modal
Close Modal